Sam – Page 453 – biolegacy

ADMA Biologics, Inc. Provides Corporate Update And Reports First Quarter 2017 Financial Results

Post author:Sam
Post published:May 14, 2017
Post category:BioPharma

Life Sciences Jobs ... Source: BioSpace

Seattle's Genoa Pharma Banks $62 Million and Names a New CEO and CSO

Post author:Sam
Post published:May 14, 2017
Post category:BioPharma

<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x450-stocks5.jpg" NAME"Seattle's Genoa Pharma Banks $62 Million and Names a New CEO and CSO" ALT"Seattle's Genoa Pharma Banks $62 Million and Names a New CEO and CSO"May 15, 2017By…

ProQR Therapeutics B.V. Remembers Co-Founder After His Unexpected Passing

Post author:Sam
Post published:May 14, 2017
Post category:BioPharma

Life Sciences Jobs ... Source: BioSpace

Safety Concerns Raised as Ionis Pharma's Inotersen Meets Both Primary Endpoints in Late-Stage Study

Post author:Sam
Post published:May 14, 2017
Post category:BioPharma

<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x450-stocks2.jpg" NAME"Safety Concerns Raised as Ionis Pharma's Inotersen Meets Both Primary Endpoints in Late-Stage Study" ALT"Safety Concerns Raised as Ionis Pharma's Inotersen Meets Both Primary Endpoints in Late-Stage Study"May…

GENFIT : Convening Notice To The Ordinary And Extraordinary Shareholders Meeting On June 16, 2017

Post author:Sam
Post published:May 14, 2017
Post category:BioPharma

Life Sciences Jobs ... Source: BioSpace

Biogen Strikes $120 Million+ Deal For Remedy Pharma's Stroke Candidate

Post author:Sam
Post published:May 14, 2017
Post category:BioPharma

Life Sciences Jobs ... Source: BioSpace

FDA Finds Repeat Deficiencies at Ohio Outsourcer

Post author:Sam
Post published:May 12, 2017
Post category:Drug Industry Daily

The FDA hit an Ohio outsourcing facility with an extensive Form 483, listing failures to adhere to GMP and overall sterility, cleaning and quality control issues—with several problems repeated from…

Celltrion Files Two Additional Petitions for PTO Review of Genentech’s Herceptin Patents

Post author:Sam
Post published:May 12, 2017
Post category:Drug Industry Daily

Celltrion has filed two petitions against a Genentech patent with the PTO, requesting an inter partes review of a method for making antibodies related to Herceptin. Source: Drug Industry Daily

Amgen Defends Neulasta Manufacturing Patent in Biosimilar Suit Against Coherus

Post author:Sam
Post published:May 12, 2017
Post category:Drug Industry Daily

Amgen is suing Coherus Biosciences over its processes for manufacturing a biosimilar of Neulasta, saying it infringes patented methods for purifying proteins. Source: Drug Industry Daily

Over 60 Members of Congress Urge CMS to Set Individual Billing Codes for Biosimilars

Post author:Sam
Post published:May 12, 2017
Post category:Drug Industry Daily

Fifty-two representatives and nine senators sent letters to HHS Secretary Tom Price and CMS Administrator Seema Verma, urging them to reverse current Medicare policy for the reimbursement for biosimilar products.…